Publication | Closed Access

Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck

6-Month Maintenance CetuximabRadiation TherapySquamous Cell CarcinomaMedicineAdjuvant Concurrent ChemoradiationHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences